Contact Us

Neurontin
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you started taking this drug:

Date you stopped taking this drug:

Was suicide attempted?

Did loved one commit suicide?

What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

If patient did commit suicide, what was the method of suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?

Please describe any psychiatric conditions diagnosed before starting Neurontin:

Did Neurontin help the condition that it was prescribed for?


Please further describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Neutrontin

Illegal Neurontin Marketing to Cost Pfizer $142.1 Million

Mar 26, 2010
| Parker Waichman LLP
Pfizer Inc. has been ordered to pay  $142.1 million in damages for violating a federal antiracketeering law in its marketing of the epilepsy...

Pfizer Influenced Neurontin Studies

Nov 12, 2009
| Parker Waichman LLP
It has been known that Neurontin is associated with a significant—80 percent, accoring to a prior LA Times report—increase in suicidal...

Neurontin Suicide Trial to Start Next Week

Jul 24, 2009
| Parker Waichman LLP
The first Neurontin suicide lawsuit is set to go to trial.  According to a report on Bloomberg.com, about 1200 similar Neurontin lawsuits are...

Illegal Marketing of Neurontin Detailed

Jan 8, 2009
| Parker Waichman LLP
An article detailing the marketing of Neurontin  recently published in the New England Journal of Medicine (NEJM) sheds new light on the tactics...

Epilepsy Drugs to Carry Suicide Warnings

Dec 17, 2008
| Parker Waichman LLP
Epilepsy drugs must now carry warnings about their suicide risks, the Food & Drug Administration (FDA) has announced.  The drugs subject to...

Pfizer Neurontin Studies Altered, Suppressed to Boost Sales

Oct 8, 2008
| Parker Waichman LLP
A lawsuit against Pfizer Inc. claims the drug maker delayed the release and altered the conclusions of Neurontin studies that did not support...

FDA Looking at Suicide Risks of Popular Drugs

Sep 2, 2008
| Parker Waichman LLP
It seems that some suicides might be linked to a variety of drugs that are surprising experts.  In one case, the Associated Press (AP) reports a...

Epilepsy Drugs Targeted for Black Box Suicide Warning

Jul 8, 2008
| Parker Waichman LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...

Neurontin Should Have Had Depression Warning, Neurologist Says

Jun 20, 2008
| Parker Waichman LLP
A British neurologist says he advised the maker of Neurontin to include a warning on its label about its potential to cause depression and...

Epilepsy Drugs to Get Suicide Warnings, FDA Confirms

Jun 6, 2008
| Parker Waichman LLP
US regulators are very close to finalizing new suicide warnings for 11 epilepsy drugs, The Wall Street Journal reported today.  This past...

Page 1/3 [first] [prev] 1 2 3 [next] [last]